COVID-19 versus SARS: A comparative review
Ahmed S. Keshta, Saad I. Mallah, Khaled Al Zubaidi, Omar Ghorab, Mohamed S. Keshta, Dalal Alarabi, Mohammad A. Abousaleh, Mustafa Thaer Salman, Omer E. Taha, Anas A. Zeidan, Mahmoud F. Elsaid, Patrick Tang
Abstract
The two genetically similar severe acute respiratory syndrome coronaviruses, SARS-CoV-1 and SARS-CoV-2, have each been responsible for global epidemics of vastly different scales. Although both viruses arose from similar origins, they quickly diverged due to differences in their transmission dynamics and spectrum of clinical presentations. The potential involvement of multiple organs systems, including the respiratory, cardiac, gastrointestinal and neurological, during infection necessitates a comprehensive understanding of the clinical pathogenesis of each virus. The management of COVID-19, initially modelled after SARS and other respiratory illnesses, has continued to evolve as we accumulate more knowledge and experience during the pandemic, as well as develop new therapeutics and vaccines. The impact of these two coronaviruses has been profound for our health care and public health systems, and we hope that the lessons learned will not only bring the current pandemic under control, but also prevent and reduce the impact of future pandemics.